一、本次减资暨关联交易事项概述 2021 年 7 月，公司与新疆慕士塔格阳光生态农牧科技有限公司（以下简称 "慕士塔格"）共同出资设立新疆天山畜牧生物育种有限公司（以下简称"育种 公司"），注册资本 3,025 万元，其中天山生物认缴出资 2,025 万元，股权占比 66.94%，慕士塔格认缴出资 1,000 万元，股权占比 33.06%。2021 年 12 月，慕士 塔格与新疆刀郎庄园新农业集团股份有限公司（以下简称"刀郎庄园"）签订《股 权转让协议》，慕士塔格将其 1,000 万元认缴出资额（其中，实缴出资 150 万元） 转让至刀郎庄园。截至目前，天山生物已全部实缴出资，刀郎庄园实缴 150 万元， 尚余 850 万元出资额尚未实缴且其确认不再实缴。根据育种公司章程，并与刀郎 庄园协商一致，育种公司拟对刀郎庄园尚未出资的 850 万元进行减资。本次减资 完成后，育种公司的注册资本由 3,025 万元减少至 2,175 万元。天山生物持有育 种公司的股权比例从 66.94%上升至 93.10%，刀郎庄园持有育种公司的股权比例 从 33.06%下降至 6.90%。 本次减资事项已经公司 2024 年 7 月 ...

经与会独立董事审议，以记名投票表决方式审议通过了《关于控股子公司减 资暨关联交易的议案》 经审核，独立董事认为：本次减资是公司与新疆刀郎庄园新农业集团股份有 限公司（以下简称"刀郎庄园"）沟通一致的结果，符合公司及新疆天山畜牧生 物育种有限公司（以下简称"育种公司"或"子公司"）发展规划和实际工作需 要，能够增强公司对子公司的控制权，进一步规范控股子公司的经营管理。本次 减资不会对公司财务及经营状况产生不利影响，不存在损害本公司及全体股东利 益的情形，符合全体股东的利益。该事项决策程序合法公正，符合《中华人民共 和国公司法》、《中华人民共和国证券法》等有关法律法规和《公司章程》的规 定。因此，我们同意育种公司对刀郎庄园尚未出资的 850 万元进行减资，并同意 将该事项提交公司第五届董事会 2024 年第四次临时会议审议。 表决结果：同意 3 票、反对 0 票、弃权 0 票。 新疆天山畜牧生物工程股份有限公司 第五届董事会独立董事专门会议 2024 年第二次临时会议决议 （以下无正文） 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）第五届董事会独 立董事专门会议 2024 年第二次临时会议（以下简称"本次 ...

证券代码：300313 证券简称：ST天山 公告编号：2024-049 新疆天山畜牧生物工程股份有限公司 2024 年 6 月活畜销售情况简报 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、2024 年 6 月销售情况简报 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）2024 年 6 月销 售活畜 148 头，销售收入 138.41 万元，环比变动分别为-77.61%、-74.67%；同 比变动分别为-81.86%、-84.39%。 二、原因说明 活畜业务中，不同用途和客户需求不同的牛只养殖周期存在差异，公司会根 据生产经营规划和市场行情变化趋势适当调整出栏时间。本月活畜销售数量、销 售收入环比、同比减少的主要原因是本月出栏牛只数量少于上月及去年同期。 三、风险提示 （一）上述数据未经审计，可能与公司定期报告披露的数据存在差异，因此 上述数据仅作为阶段性数据供投资者参考。 （二）上述披露仅包含公司活畜销售情况，不含其它业务。 （三）《证券时报》《上海证券报》以及巨潮资讯网（www.cninfo.com.cn） 为公司指定的信息披露媒体，公司所有信 ...

Financial Performance - The company's revenue for Q3 2023 reached ¥49,233,973.63, representing a 182.78% increase year-over-year[5] - Net profit attributable to shareholders was ¥99,501.92, a 100.61% increase compared to the same period last year[5] - Total operating revenue for the third quarter reached ¥95,556,468.24, a significant increase of 105.6% compared to ¥46,438,688.52 in the same period last year[34] - Total operating costs amounted to ¥107,186,932.20, up 59.5% from ¥67,220,917.63 year-over-year[34] - The net loss for the quarter was ¥12,905,285.94, an improvement from a net loss of ¥28,568,998.45 in the previous year, representing a reduction of 54.8%[35] - The company's gross profit margin decreased to -12.1% from -44.0% year-over-year, indicating improved operational efficiency despite a net loss[34] - Investment income for the quarter was ¥2,462,959.89, a recovery from a loss of ¥8,430,409.24 in the same period last year[35] - The total equity attributable to shareholders of the parent company decreased to ¥71,223,967.16 from ¥84,261,480.39, indicating a decline in retained earnings[35] - The company reported a basic and diluted earnings per share of -0.0417, an improvement from -0.0904 in the same quarter last year[35] Assets and Liabilities - The total assets at the end of the reporting period were ¥318,267,849.41, a decrease of 4.18% from the previous year-end[5] - The company's current assets totaled CNY 108,406,607.62, down from CNY 117,638,304.71 at the start of the year, indicating a decline of approximately 10.5%[30] - The company's total liabilities were CNY 224,954,903.65, slightly down from CNY 225,759,429.69, indicating a marginal decrease of about 0.4%[31] - The total liabilities stood at ¥237,005,183.98, slightly down from ¥237,977,656.18 in the previous quarter[35] - Short-term borrowings decreased to CNY 83,324,712.50 from CNY 94,159,536.10, a reduction of approximately 11.5%[31] Cash Flow - Cash flow from operating activities showed a net outflow of ¥15,921,844.76, a significant decline of 476.87% year-to-date[5] - Operating cash inflow for the period was CNY 89,646,297.27, an increase from CNY 68,572,797.25 in the previous period, representing a growth of approximately 30.7%[36] - Net cash outflow from operating activities was CNY -15,921,844.76, worsening from CNY -2,760,039.21 in the previous period[36] - Cash inflow from financing activities totaled CNY 138,890,000.00, up from CNY 124,480,000.00, indicating an increase of about 11.5%[37] - Cash and cash equivalents decreased to CNY 15,971,162.89 from CNY 47,288,291.92, representing a significant drop of about 66.2%[30] - Cash and cash equivalents at the end of the period decreased to CNY 15,971,162.89 from CNY 70,520,414.30, a decline of approximately 77.6%[37] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,640[13] - The company reported a total of 40,718,359 shares to be transferred, representing 13.01% of the total shares, as part of a control transfer agreement with China Electric Power Investment New Agricultural Innovation Technology Co., Ltd.[16] - The company’s major shareholder, Huzhou Haohui Enterprise Management Consulting Co., Ltd., holds 69,211,312 shares, accounting for 22.11% of the total share capital, with 15,350,000 shares pledged, which is 4.90% of the total share capital.[19] - The company’s major shareholder, Chen Dehong, has 37,279,083 shares, with 36,509,768 shares pledged, representing 97.94% of his holdings and 11.67% of the total share capital.[20] - The company’s control structure may change to a state of no actual controller if the proposed share transfer is completed.[16] Legal Proceedings - The company has been involved in legal proceedings related to the former actual controller, resulting in the recovery of 37,279,083 shares and 78,345,524 shares from the former shareholders of Elephant Advertising Co., Ltd.[18] - The company is involved in ongoing legal proceedings related to contract fraud, with significant implications for its financial standing and operations[24] - The company received a court ruling to cancel stock held by 30 defendants, which may impact its equity structure and future financial performance[24] Inventory and Accounts Payable - The company's inventory increased by 34.95% to ¥73,100,987.42, attributed to business expansion[10] - The company experienced a 109.99% increase in accounts payable, reaching ¥22,884,212.96, due to business expansion[10] - Accounts receivable increased to CNY 10,860,306.47 from CNY 7,966,972.32, reflecting a growth of approximately 36.5%[30] - Inventory rose to CNY 73,100,987.42 from CNY 54,170,780.11, marking an increase of about 35%[30] Research and Development - Research and development expenses increased to ¥764,036.98, up 111.1% from ¥361,344.55 year-over-year, reflecting the company's commitment to innovation[34] Other Financial Information - The company did not conduct an audit for the third-quarter report[38] - Other comprehensive income after tax amounted to ¥11,980,296.36, contributing positively to the overall financial position despite the net loss[35] - The company reported a cash flow impact from exchange rate changes of CNY 16.97, a significant decrease from CNY 923,060.71 in the previous period[37]

Revenue Adjustments - The company corrected its 2023 semi-annual report and third-quarter report due to overlapping relationships with suppliers and customers, resulting in a revenue adjustment of CNY 1,034,400 for Q2, CNY 17,342,604 for the first three quarters, and CNY 922,710 for Q4[3][10][12]. - The corrected total operating revenue for the first half of 2023 is CNY 46,322,494.61, down from CNY 47,356,894.61, reflecting a decrease of approximately 2.18%[4]. - The company reported a total operating revenue of CNY 95,556,468.24 for the first three quarters of 2023, down from CNY 112,899,072.24, representing a decline of approximately 15.3%[4]. Cost Adjustments - The total operating costs for the first half of 2023 were adjusted to CNY 58,557,358.46 from CNY 59,591,758.46, indicating a reduction of about 1.74%[4]. - The total operating costs for the first three quarters were adjusted to CNY 107,186,932.20 from CNY 124,529,536.20, reflecting a decrease of about 13.6%[4]. Cash Flow Adjustments - The cash received from sales and services for the first half of 2023 was revised to CNY 42,041,707.30, a decrease of CNY 1,034,400 from the previous figure[4]. - Cash received from sales and services for the first three quarters was revised to CNY 82,672,046.71, a decrease of CNY 17,400,204.00 from the previous amount[4]. Compliance and Apologies - The company emphasized its commitment to improving internal controls and compliance with regulatory requirements to prevent similar issues in the future[13]. - The adjustments do not affect the previously disclosed total profit, net profit, or net profit attributable to shareholders for the 2023 annual report[12]. - The company expressed sincere apologies for any inconvenience caused to investors due to these corrections[6].

Financial Performance - The company achieved total operating revenue of 46.3225 million yuan, an increase of 59.58% year-on-year[15]. - The operating profit was -13.4891 million yuan, a year-on-year increase in loss of 16.34%[15]. - The total profit amounted to -12.1134 million yuan, with a year-on-year increase in loss of 3.12%[15]. - The net profit attributable to shareholders of the parent company was -13.137 million yuan, reflecting a year-on-year increase in loss of 9.37%[15]. - The company's operating revenue for the first half of 2023 was ¥46,322,494.61, representing a 59.58% increase compared to ¥29,027,767.83 in the same period last year[47]. - The net profit attributable to shareholders was -¥13,137,015.15, a decrease of 9.37% from -¥12,011,071.53 year-on-year[47]. - The net cash flow from operating activities was -¥11,860,704.65, reflecting a significant decline of 386.73% compared to -¥2,436,813.41 in the previous year[47]. - The operating costs increased by 70.26% to ¥43,633,045.26 from ¥25,626,778.38, reflecting the costs associated with the expanded beef cattle farming[108]. - The net cash flow from operating activities was -¥11,860,704.65, a decrease of 386.73% compared to -¥2,436,813.41, mainly due to increased inventory purchases and differing cash collection cycles[108]. Assets and Equity - As of June 30, 2023, total assets were 315.5853 million yuan, a decrease of 4.99% from the beginning of the year[15]. - Current assets decreased by 10.66%, while non-current assets decreased by 1.88%[15]. - Shareholders' equity attributable to the listed company was 71.1245 million yuan, down 15.59% from the beginning of the year[15]. - The total assets at the end of the reporting period were ¥315,585,297.38, down 4.99% from ¥332,145,607.55 at the end of the previous year[47]. - The net assets attributable to shareholders decreased by 15.59%, from ¥84,261,480.39 to ¥71,124,465.24[47]. Market and Pricing - The average price of fattening cattle in the first half of 2023 was 31.08 yuan/kg, a year-on-year decrease of 12.6%[36]. - The average price of fattening cattle in June 2023 dropped to 25.39 yuan/kg, the lowest since November 2017[36]. - The company’s milk revenue was CNY 982,241.79, with a gross margin of -105.99%[92]. - The revenue from live cattle sales was CNY 29,949,317.14, showing a decline of 4.31% year-on-year[92]. Business Strategy and Operations - The company plans not to distribute cash dividends or issue bonus shares[3]. - The company has initiated the establishment of a breeding engineering research center, which is expected to enhance its capabilities in frozen semen and breeding research[52]. - The company is focusing on optimizing resource allocation and revitalizing idle assets to increase annual operating income[62]. - The company has expanded its procurement and sales models to stabilize customer resources and enhance business scalability[53]. - The company aims to achieve an increase in revenue for the entire year by adjusting its management structure and focusing on core business development[76]. - The company is focused on enhancing its governance structure by incorporating industry professionals into its management team[76]. - The company is focused on expanding its agricultural development capabilities, as indicated by the acquisition of multiple land plots for agricultural use[85]. - The company is actively involved in the development of new agricultural technologies, as evidenced by its land acquisitions for agricultural development[86]. - The company has plans for future expansion in the agricultural sector, with multiple land plots acquired for development purposes[86]. Research and Development - The company achieved a 15% reduction in production costs through quality and yield improvement trials for frozen semen production[52]. - Research and development expenses rose by 101.55% to ¥461,185.97 from ¥228,820.64, primarily due to an increase in R&D personnel[108]. - The company has implemented new technologies in breeding, which have improved the fertility rate by 15%[161]. - Research and development expenses for the period amounted to 8 million CNY, focusing on genetic improvement technologies[175]. Challenges and Industry Context - The company faces significant barriers to large-scale beef cattle farming, including high capital requirements and a lack of skilled management personnel[102]. - The domestic beef consumption gap has increased significantly, reaching 269,000 tons in 2022, which accounts for 26% of the total beef consumption that year[122]. - The overall beef production in China has grown from 610.71 million tons in 2011 to 712.5 million tons in 2022, with a compound annual growth rate of approximately 1%[122]. - The company recognizes the importance of expanding live cattle breeding scale and implementing cost reduction and efficiency improvement strategies, focusing on beef cattle breeding business[150]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,649[195]. - The largest shareholder, Huzhou Haohui Enterprise Management Consulting Co., Ltd., holds 22.11% of shares, totaling 69,211,312 shares[195]. - Chen Dehong, a natural person, holds 11.91% of shares, totaling 37,279,083 shares[195]. - The state-owned enterprise Wuhu Huarong Yuwen holds 10.55% of shares, totaling 33,025,998 shares[195]. - The state-owned Investment Center (Limited Partnership) holds 4.36% of shares, totaling 13,631,462 shares[195]. - The state-owned Huarong Tianze Investment Co., Ltd. holds 3.62% of shares, totaling 11,335,123 shares[195]. - Liu Baiquan, a natural person, holds 2.69% of shares, totaling 8,424,390 shares[195]. - The total number of shares held by shareholders with special voting rights is 0[195]. - There are no changes in the shareholding of directors, supervisors, and senior management during the reporting period[196]. - The company does not have any differential voting rights arrangements[196].

证券代码：300313 证券简称：ST天山 公告编号：2024-045 新疆天山畜牧生物工程股份有限公司 关于新疆证监局对公司采取责令改正措施的整改报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）于 2024 年 6 月 3 日收到中国证券监督管理委员会新疆监管局（以下简称"新疆证监局"）下发 的《行政监管措施决定书》（〔2024〕13 号）（以下简称"《决定书》"）， 具体内容详见公司于 2024 年 6 月 4 日披露的《关于收到行政监管措施决定书的 公告》（公告编号：2024-041）。 收到《决定书》后，公司高度重视，就《决定书》所提出的相关问题进行全 面梳理，同时结合公司实际情况，就《决定书》中提出的问题和要求切实进行整 改，现将公司具体的整改情况报告如下： 一、《决定书》提及的问题 《决定书》指出："2023 年，你公司活畜业务部分供应商与客户重叠或存 在借贷、劳务等密切关系，基于谨慎性原则，分别调减第二季度、第三季度、第 四季度活畜销售收入 103.44 万元、1,630.82 万元、92 ...

证券代码：300313 证券简称：ST天山 公告编号：2024-044 新疆天山畜牧生物工程股份有限公司 关于控股股东被申请实质合并破产清算的公告 截止本公告日，湖州皓辉持有公司股份数量为 69,211,312 股，占公司股份 总数的 22.11%。如果对中植集团等 248 家企业的实质合并破产清算申请被北京 一中院受理，湖州皓辉进入实质合并破产清算程序，将可能对公司的股权结构产 生影响。公司与控股股东在业务、人员、资产、机构、财务等方面均保持相互独 立，控股股东被申请实质合并破产清算不会对公司日常生产经营产生影响。截至 目前，公司生产经营情况正常。 公司和控股股东将持续关注该事项进展情况，并按照相关规定及时履行信息 披露义务。公司郑重提醒广大投资者：《证券时报》《上海证券报》及巨潮资讯 网为公司选定的信息披露媒体，公司所有信息均以在上述媒体披露的信息为准， 请广大投资者理性投资，注意风险。 特此公告。 新疆天山畜牧生物工程股份有限公司董事会 二〇二四年六月二十八日 1 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新疆天山畜牧生物工程股份有限公司（以下简称 ...

证券代码：300313 证券简称：ST天山 公告编号：2024-042 新疆天山畜牧生物工程股份有限公司 关于参加新疆辖区上市公司 2024 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，新疆天山畜牧生物工程股份有限公司 （以下简称“公司”）将参加由新疆上市公司协会根据新疆证监局工作部署，联 合深圳市全景网络有限公司举办的“2024 年新疆辖区上市公司投资者网上集体 接待日活动”，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录“全景路演”网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP， 参与本次互动交流，活动时间为 2024 年 6 月 14 日（周五）16:00-18:00。届时 公司高管将在线就公司 2023 年度业绩、公司治理、发展战略、经营状况、融资 计划、股权激励和可持续发展等投资者关心的问题，与投资者进行沟通交流，欢 迎广大投资者踊跃参与。 特此公告。 ...